Ap2A1 Protein (Adaptor Related Protein Complex 2 Alpha 1) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
:: infobox .infobox-protein
| AP2A1 Protein (Adaptor-Related Protein Complex 2 Alpha 1) | |
|---|---|
| Gene | AP2A1 |
| UniProt | O95782 |
| Molecular Weight | ~130 kDa |
| Subcellular Localization | Clathrin-coated pits |
| Protein Family | Adaptor protein complex family |
| Aliases | AP-2, CLASP |
===
AP2A1 is the alpha subunit of the adaptor protein complex 2 (AP-2), a heterotetrameric complex that functions in clathrin-mediated endocytosis. The protein contains an N-terminal trunk domain, a hinge region, and a C-terminal ear domain.
AP-2 regulates:
AP2A1 dysfunction contributes to:
AP-2 complex dysregulation affects:
AP-2 complex components are being studied as therapeutic targets for:
The study of Ap2A1 Protein (Adaptor Related Protein Complex 2 Alpha 1) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The AP2A1 Protein is a protein involved in various cellular processes in the nervous system. This protein plays important roles in neuronal function, signal transduction, and cellular homeostasis. Dysfunction of this protein has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
The AP2A1 Protein participates in multiple molecular pathways critical for neuronal health. It is expressed in various brain regions and cell types, where it contributes to synaptic transmission, membrane potential regulation, and intracellular signaling cascades.
Alterations in AP2A1 Protein expression or function have been associated with several neurodegenerative conditions. Research suggests that this protein may serve as a therapeutic target for disease modification in AD, PD, and related disorders.